Company Filing History:
1 out of 123 
1 out of 2 
1 out of 832,912 Years Active: 1999-2006
Title: Paul M Mathews: Innovator in Neurodegenerative Disease Research
Introduction
Paul M Mathews is a notable inventor based in Irvington, NY (US), recognized for his contributions to the field of neurodegenerative diseases. He holds 3 patents that focus on innovative methods for diagnosing and treating conditions such as Alzheimer's disease. His work has significant implications for improving the quality of life for patients suffering from neuronal atrophy-associated dementia.
Latest Patents
Mathews' latest patents include groundbreaking methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia. This invention features methods of diagnosing and treating patients with Alzheimer's disease by determining or altering the level of activity of pathways from the endoplasmic reticulum to lysosomes. Another significant patent focuses on identifying compounds useful for the treatment of Alzheimer's disease, showcasing his commitment to advancing medical research in this critical area.
Career Highlights
Throughout his career, Mathews has worked with esteemed organizations such as the McLean Hospital Corporation and the Nathan S. Kline Institute for Psychiatric Research. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and innovation capabilities.
Collaborations
Mathews has collaborated with notable colleagues, including Ralph A Nixon and Anne M Cataldo. These partnerships have contributed to the development of his innovative approaches to treating neurodegenerative diseases.
Conclusion
Paul M Mathews stands out as a significant figure in the realm of neurodegenerative disease research. His patents and collaborations reflect his dedication to improving patient outcomes and advancing scientific knowledge in this vital area.